| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| REGNRegeneron Pharmaceuticals, Inc. | 107.56B | 781.67 | 18.84 | 0.99% | 31.41% | 14.41% | 3.79% | 0.09 |
| CTMXCytomX Therapeutics, Inc. | 430.14M | 5.37 | 14.13 | 36.45% | 24.66% | 26.09% | ||
| PRTCPureTech Health plc | 405.3M | 16.77 | 8.39 | 44.98% | -495.91% | -8.53% | 0.05 | |
| DNAGinkgo Bioworks Holdings, Inc. | 327.53M | 6.75 | -1.20 | -25.06% | -183.81% | -61.5% | 0.82 | |
| BCYCBicycle Therapeutics plc | 111.38M | 5.73 | -1.98 | 30.76% | -8.85% | -40.53% | 0.01 | |
| CCCCC4 Therapeutics, Inc. | 261.67M | 2.70 | -2.13 | -100% | -40.92% | 0.23 | ||
| MOLNMolecular Partners AG | 187.84M | 5.02 | -2.43 | -29.38% | -10.87% | -63.06% | 0.02 | |
| RXRXRecursion Pharmaceuticals, Inc. | 1.94B | 3.67 | -2.55 | 26.92% | -8.65% | -57.01% | 0.07 |
Analyze head-to-head performance against top industry competitors across valuation, growth, and profitability metrics.
| Nov 2018 | Nov 2019 | Nov 2020 | Nov 2021 | Nov 2022 | Nov 2023 | Nov 2024 | Nov 2025 | |
|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 37.45M | 31.11M | 17.82M | 29.75M | 38.63M | 76.99M | 54.55M | 83.98M |
| Revenue Growth % | - | -16.91% | -42.73% | 66.95% | 29.84% | 99.31% | -29.15% | 53.95% |
| Cost of Goods Sold | 40.51M | 45.02M | 66.49M | 116.43M | 184.5M | 189.15M | 221.63M | 18.86M |
| COGS % of Revenue | 108.18% | 144.71% | 373.14% | 391.37% | 477.64% | 245.69% | 406.3% | 22.45% |
| Gross Profit | -3.06M | -13.91M | -48.67M | -86.68M | -145.87M | -112.16M | -167.08M | 65.12M |
| Gross Margin % | -8.18% | -44.71% | -273.14% | -291.37% | -377.64% | -145.69% | -306.3% | 77.55% |
| Gross Profit Growth % | - | -353.83% | -249.92% | -78.09% | -68.28% | 23.11% | -48.97% | 138.98% |
| Operating Expenses | 6.67M | 8.33M | 16.31M | 31.2M | 38M | 42.9M | 45.94M | 350.79M |
| OpEx % of Revenue | 17.82% | 26.76% | 91.52% | 104.88% | 98.37% | 55.73% | 84.23% | 417.71% |
| Selling, General & Admin | 6.67M | 8.33M | 16.31M | 31.2M | 38M | 42.9M | 45.94M | 52.74M |
| SG&A % of Revenue | 17.82% | 26.76% | 91.52% | 104.88% | 98.37% | 55.73% | 84.23% | 62.8% |
| Research & Development | 40.51M | 45.02M | 66.49M | 116.43M | 184.5M | 189.15M | 221.63M | 308.16M |
| R&D % of Revenue | 108.18% | 144.71% | 373.14% | 391.37% | 477.64% | 245.69% | 406.3% | 366.95% |
| Other Operating Expenses | -40.51M | -45.02M | -66.49M | -116.43M | -184.5M | -189.15M | -221.63M | -10.12M |
| Operating Income | -9.74M | -22.24M | -64.98M | -117.89M | -183.87M | -155.06M | -213.03M | -285.67M |
| Operating Margin % | -26.01% | -71.46% | -364.66% | -396.26% | -476.01% | -201.41% | -390.52% | -340.16% |
| Operating Income Growth % | - | -128.32% | -192.24% | -81.41% | -55.97% | 15.67% | -37.38% | -34.1% |
| EBITDA | -6.75M | -19.88M | -62.8M | -115.9M | -179.72M | -148.93M | -205.01M | -266.81M |
| EBITDA Margin % | -18.03% | -63.9% | -352.43% | -389.57% | -465.27% | -193.45% | -375.83% | -317.71% |
| EBITDA Growth % | - | -194.5% | -215.88% | -84.54% | -55.07% | 17.13% | -37.65% | -30.15% |
| D&A (Non-Cash Add-back) | 2.99M | 2.35M | 2.18M | 1.99M | 4.15M | 6.13M | 8.02M | 18.86M |
| EBIT | -9.74M | -22.24M | -64.98M | -117.89M | -183.87M | -155.06M | -213.03M | -263.7M |
| Net Interest Income | 818K | 776K | 1.21M | 823K | 3.51M | 11.12M | 19.73M | 21.97M |
| Interest Income | 818K | 776K | 1.21M | 823K | 3.51M | 11.12M | 19.73M | 21.97M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 818K | 776K | 1.21M | 823K | 3.51M | 11.12M | 19.73M | 21.97M |
| Pretax Income | -8.92M | -21.46M | -63.78M | -117.06M | -180.36M | -143.95M | -193.3M | -263.7M |
| Pretax Margin % | -23.82% | -68.97% | -357.9% | -393.49% | -466.93% | -186.98% | -354.36% | -314% |
| Income Tax | 507K | 239K | -20.54M | 131K | 0 | 0 | 270K | 760K |
| Effective Tax Rate % | 105.68% | 101.11% | 67.8% | 100.11% | 100% | 100% | 100.14% | 100.29% |
| Net Income | -9.43M | -21.7M | -43.24M | -117.19M | -180.36M | -143.95M | -193.57M | -264.46M |
| Net Margin % | -25.18% | -69.74% | -242.66% | -393.93% | -466.93% | -186.98% | -354.85% | -314.9% |
| Net Income Growth % | - | -130.15% | -99.28% | -171.02% | -53.9% | 20.19% | -34.47% | -36.62% |
| Net Income (Continuing) | -9.43M | -21.7M | -43.24M | -117.19M | -180.36M | -143.95M | -193.57M | -264.46M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.59 | -0.56 | -2.76 | -2.73 | -3.71 | -2.65 | -2.88 | -3.05 |
| EPS Growth % | - | 5.08% | -392.86% | 1.09% | -35.9% | 28.57% | -8.68% | -5.9% |
| EPS (Basic) | -0.59 | -0.56 | -2.76 | -2.73 | -3.71 | -2.65 | -2.88 | -3.05 |
| Diluted Shares Outstanding | 16.11M | 38.85M | 15.67M | 42.9M | 48.61M | 54.34M | 67.12M | 86.67M |
| Basic Shares Outstanding | 16.11M | 38.85M | 15.67M | 42.9M | 48.61M | 54.34M | 67.12M | 86.67M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - |
| Nov 2018 | Nov 2019 | Nov 2020 | Nov 2021 | Nov 2022 | Nov 2023 | Nov 2024 | Nov 2025 | |
|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 40.65M | 39.35M | 298.43M | 311.12M | 318.45M | 295.5M | 619.39M | 606.82M |
| Cash & Short-Term Investments | 39.04M | 37.72M | 281.15M | 295.72M | 309.14M | 287.91M | 609.58M | 592.94M |
| Cash Only | 25.59M | 34.82M | 119.36M | 80.51M | 64.47M | 54.63M | 110M | 246.96M |
| Short-Term Investments | 13.45M | 2.9M | 161.79M | 215.21M | 244.67M | 233.28M | 499.59M | 345.98M |
| Accounts Receivable | 0 | 0 | 11.35M | 6.2M | 1.1M | 800K | 1.5M | 0 |
| Days Sales Outstanding | - | - | 232.4 | 76.12 | 10.39 | 3.79 | 10.04 | - |
| Inventory | 0 | 0 | 0 | 0 | -1.1M | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - |
| Other Current Assets | 0 | 0 | 0 | 900K | 9.31M | 6.79M | 8.3M | 13.88M |
| Total Non-Current Assets | 4.74M | 4.69M | 97.91M | 165.65M | 98.31M | 60.09M | 49.96M | 81.32M |
| Property, Plant & Equipment | 4.42M | 3.87M | 6.67M | 25.34M | 29.51M | 47.95M | 45.9M | 73.01M |
| Fixed Asset Turnover | 8.47x | 8.04x | 2.67x | 1.17x | 1.31x | 1.61x | 1.19x | 1.15x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 170K | 506K | 90.89M | 137.47M | 63.88M | 7.42M | 0 | 0 |
| Other Non-Current Assets | 151K | 317K | 347K | 3.12M | 4.92M | 4.72M | 4.06M | 8.31M |
| Total Assets | 45.4M | 44.05M | 396.34M | 476.77M | 416.76M | 355.6M | 669.34M | 688.13M |
| Asset Turnover | 0.82x | 0.71x | 0.04x | 0.06x | 0.09x | 0.22x | 0.08x | 0.12x |
| Asset Growth % | - | -2.97% | 799.8% | 20.29% | -12.59% | -14.68% | 88.23% | 2.81% |
| Total Current Liabilities | 32.83M | 16.14M | 44.54M | 66.26M | 70.66M | 86.96M | 95.85M | 86.47M |
| Accounts Payable | 1.3M | 1.6M | 3.41M | 6.65M | 5.06M | 6.4M | 11.48M | 11.21M |
| Days Payables Outstanding | 11.69 | 12.95 | 18.73 | 20.85 | 10.02 | 12.35 | 18.91 | 217.09 |
| Short-Term Debt | 0 | 0 | 0 | 3.85M | 5.53M | 7.49M | 0 | 0 |
| Deferred Revenue (Current) | 28.42M | 9.61M | 32.8M | 41.21M | 37.63M | 48.1M | 38.36M | 17.58M |
| Other Current Liabilities | 726K | 1.18M | 2.6M | 5.67M | 9.14M | 751K | 18.91M | 23.64M |
| Current Ratio | 1.24x | 2.44x | 6.70x | 4.70x | 4.51x | 3.40x | 6.46x | 7.02x |
| Quick Ratio | 1.24x | 2.44x | 6.70x | 4.70x | 4.52x | 3.40x | 6.46x | 7.02x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 49.41M | 85.63M | 61.53M | 68.21M | 42.41M | 68.15M | 46.5M | 62.92M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 9.19M | 6.43M | 23.13M | 20.29M | 52.91M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 1.22M | 1.74M | 850K | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 34.05M | 53.57M | 106.07M | 134.47M | 113.06M | 155.1M | 142.35M | 149.39M |
| Total Debt | 0 | 0 | 0 | 13.04M | 11.96M | 30.61M | 28.3M | 55.73M |
| Net Debt | -25.59M | -34.82M | -119.36M | -67.47M | -52.51M | -24.01M | -81.69M | -191.23M |
| Debt / Equity | - | - | - | 0.04x | 0.04x | 0.15x | 0.05x | 0.10x |
| Debt / EBITDA | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - |
| Total Equity | -36.85M | -57.71M | 290.27M | 342.3M | 303.7M | 200.49M | 526.99M | 538.75M |
| Equity Growth % | - | -56.63% | 602.94% | 17.93% | -11.28% | -33.98% | 162.85% | 2.23% |
| Book Value per Share | -2.29 | -1.49 | 18.52 | 7.98 | 6.25 | 3.69 | 7.85 | 6.22 |
| Total Shareholders' Equity | -36.85M | -57.71M | 290.27M | 342.3M | 303.7M | 200.49M | 526.99M | 538.75M |
| Common Stock | 3K | 4K | 39K | 45K | 47K | 49K | 76K | 102K |
| Retained Earnings | -38.76M | -60.46M | -103.7M | -220.89M | -401.25M | -545.2M | -738.77M | -1B |
| Treasury Stock | -1.9M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -4K | -2K | 87K | -608K | -4.32M | -655K | 150K | 105K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Nov 2018 | Nov 2019 | Nov 2020 | Nov 2021 | Nov 2022 | Nov 2023 | Nov 2024 | Nov 2025 | |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -31.68M | 601K | -80K | -84.36M | -159.81M | -81.36M | -172.58M | -249.47M |
| Operating CF Margin % | -84.58% | 1.93% | -0.45% | -283.58% | -413.72% | -105.69% | -316.38% | -297.05% |
| Operating CF Growth % | - | 101.9% | -113.31% | -105356.25% | -89.42% | 49.09% | -112.11% | -44.55% |
| Net Income | -9.43M | -21.7M | -43.24M | -117.19M | -180.36M | -143.95M | -193.57M | -264.46M |
| Depreciation & Amortization | 2.99M | 2.35M | 2.18M | 6.08M | 10.81M | 13.65M | 16.43M | 18.86M |
| Stock-Based Compensation | 431K | 510K | 4.3M | 15.8M | 28.13M | 33.67M | 33.93M | 37.97M |
| Deferred Taxes | -354K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -6K | -109K | 273K | 1.83M | 636K | -4.87M | -10.97M | -10.23M |
| Working Capital Changes | -25.31M | 19.55M | 36.41M | 9.11M | -19.02M | 20.12M | -18.4M | -31.6M |
| Change in Receivables | 12.37M | 0 | -11.35M | -6M | 6M | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 6.77M | 0 | 0 | 0 | 0 |
| Change in Payables | -519K | 302K | 1.23M | 1.59M | 85K | 1.61M | 5.21M | -630K |
| Cash from Investing | 39.99M | 8.5M | -254.4M | -108.25M | 27.2M | 68.3M | -257.71M | 147.85M |
| Capital Expenditures | -1.59M | -1.65M | -4.55M | -5.66M | -12.24M | -8.4M | -9.27M | -14M |
| CapEx % of Revenue | 4.26% | 5.31% | 25.55% | 19.03% | 31.7% | 10.91% | 17% | 16.67% |
| Acquisitions | 6K | -10.15M | 249.85M | 102.59M | -39.44M | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 10.15M | -249.85M | -102.59M | 39.44M | 0 | 0 | 0 |
| Cash from Financing | 529K | 126K | 339.02M | 153.88M | 117.19M | 3.22M | 485.67M | 238.64M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 529K | 126K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -2K | -16K | -7K | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 963K | 3.73M | 97.79M | 0 | 7.17M | 0 |
| Net Change in Cash | 8.85M | 9.22M | 84.54M | -38.73M | -15.42M | -9.85M | 55.37M | 137.03M |
| Free Cash Flow | -33.27M | -1.05M | -4.63M | -90.03M | -172.05M | -89.77M | -181.86M | -263.47M |
| FCF Margin % | -88.84% | -3.37% | -26% | -302.61% | -445.42% | -116.6% | -333.38% | -313.73% |
| FCF Growth % | - | 96.84% | -341.24% | -1843.15% | -91.11% | 47.83% | -102.59% | -44.88% |
| FCF per Share | -2.07 | -0.03 | -0.30 | -2.10 | -3.54 | -1.65 | -2.71 | -3.04 |
| FCF Conversion (FCF/Net Income) | 3.36x | -0.03x | 0.00x | 0.72x | 0.89x | 0.57x | 0.89x | 0.94x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 1K | 1K | 1K | 481K | 0 | 0 | 0 | 0 |
| Metric | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | - | -37.19% | -37.05% | -55.84% | -57.1% | -53.22% | -49.63% |
| Return on Invested Capital (ROIC) | - | - | -124.36% | -39.67% | -52.43% | -54.39% | -51.39% | -54.05% |
| Gross Margin | -8.18% | -44.71% | -273.14% | -291.37% | -377.64% | -145.69% | -306.3% | 77.55% |
| Net Margin | -25.18% | -69.74% | -242.66% | -393.93% | -466.93% | -186.98% | -354.85% | -314.9% |
| Debt / Equity | - | - | - | 0.04x | 0.04x | 0.15x | 0.05x | 0.10x |
| FCF Conversion | 3.36x | -0.03x | 0.00x | 0.72x | 0.89x | 0.57x | 0.89x | 0.94x |
| Revenue Growth | - | -16.91% | -42.73% | 66.95% | 29.84% | 99.31% | -29.15% | 53.95% |
Explore detailed financial history, valuation models, and returns analysis
DCF models, peer multiples & analyst estimates
Historical returns with dividends reinvested
Yield, growth, payout safety & DRIP calculator
EPS trends, net income & profitability analysis
Long-term charts & historical price data
Sales growth patterns & revenue breakdown
30 years of valuation, profitability & efficiency metrics